MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

NCT07574047 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

108

Enrollment

OTHER

Sponsor class

Conditions

Melanoma
Advanced Melanoma

Interventions

DRUG: Immune Checkpoint Inhibitors
DRUG: Immune Checkpoint Inhibitors

Sponsor

Swiss Cancer Institute